US 12091386
D-amphetamine compounds, compositions, and processes for making and using the same
granted A61KA61K31/4458A61K31/4545
Quick answer
US patent 12091386 (D-amphetamine compounds, compositions, and processes for making and using the same) held by Zevra Therapeutics, Inc. expires Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Zevra Therapeutics, Inc.
- Grant date
- Tue Sep 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/4458, A61K31/4545, A61K47/55, A61K9/0019